CA Stock MarketDetailed Quotes
KNE Kane Biotech Inc
- 0.140
- +0.005+3.70%
15min DelayMarket Closed Jul 18 16:00 ET
18.55MMarket Cap-3500P/E (TTM)
0.145High0.140Low16.00KVolume0.145Open0.135Pre Close2.29KTurnover0.17052wk High0.02%Turnover Ratio132.51MShares0.05052wk Low-0.04EPS TTM11.92MFloat Cap4.500Historical HighLossP/E (Static)85.12MShs Float0.050Historical Low-0.04EPS LYR3.70%Amplitude--Dividend TTM-1.57P/B1Lot Size--Div YieldTTM
Kane Biotech Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2.31%-755K | -2.55%-2.72M | -1,194.58%-1.43M | 27.88%-715.27K | 10.47%-737.95K | -15.95%-2.65M | -20.29%-110.43K | -15.56%-991.76K | 19.68%-733.01K | -93.24%-824.29K |
| Net income from continuing operations | -8.21%-1.35M | -37.82%-5.27M | -92.32%-1.61M | -39.12%-1.45M | -8.03%-1.24M | 21.15%-3.82M | 33.33%-838.15K | 34.36%-1.04M | 20.45%-794.6K | -13.97%-1.15M |
| Operating gains losses | --77 | 3,186.79%153K | 90.60%9.67K | 8,725.90%35.97K | ---- | -92.97%4.66K | --5.07K | -100.63%-417 | ---- | ---5.21K |
| Depreciation and amortization | -10.77%54.11K | -7.41%238.59K | -19.67%48.3K | -0.98%63.99K | 3.00%60.65K | 37.09%257.68K | -1.78%60.13K | 11.50%64.63K | 57.51%74.04K | 170.38%58.88K |
| Remuneration paid in stock | ---- | --0 | ---- | ---- | ---- | --178.2K | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | 728.30%221.97K | 58.06%441.93K | 638.13%213.28K | 382.07%230.02K | -130.27%-35.33K | -74.40%279.6K | -79.79%28.9K | -94.24%47.71K | 61.26%86.3K | 73.34%116.69K |
| Other non cashItems | -42.17%169.66K | 118.26%1.12M | 15.49%367.83K | 34.44%283.97K | 444.35%293.37K | 759.61%515.3K | 893.38%318.5K | 597.86%211.23K | 651.59%70.76K | -593.06%-85.2K |
| Change In working capital | -22.35%146.01K | 997.88%589.99K | -433.62%-456.79K | 142.18%116.35K | -22.52%188.04K | -105.08%-65.71K | -86.33%136.92K | -48.84%-275.82K | -11,779.05%-169.51K | -49.22%242.7K |
| -Change in receivables | -140.29%-10.08K | -97.92%5.82K | -140.68%-218.72K | 94.32%-20.78K | -87.65%25.03K | 529.66%279.57K | 35.30%537.68K | 38.32%-365.81K | -880.61%-95.04K | -18.82%202.74K |
| -Change in inventory | 120.18%7.6K | -60.30%-113.47K | -285.86%-121.42K | 238.77%109.72K | -247.92%-37.67K | -49.67%-70.79K | 206.86%65.33K | -191.71%-79.06K | 7.83%-82.52K | 48.50%25.47K |
| -Change in payables and accrued expense | 30.62%284.2K | 189.83%199.04K | 233.60%316.88K | -41.95%119.15K | 153.65%217.58K | -128.32%-221.58K | -203.97%-237.19K | -53.19%205.27K | -86.81%-275.44K | -67.39%85.78K |
| -Change in other current assets | -1,429.01%-86.13K | -234.74%-54.67K | 51.55%62.03K | -475.04%-58.86K | 118.30%6.48K | 548.03%40.57K | 79.50%40.93K | 535.97%15.7K | -13.25%19.36K | -0.43%-35.41K |
| -Change in other working capital | -112.12%-49.58K | 691.81%553.28K | -83.66%-495.56K | 36.68%-32.87K | 34.85%-23.37K | -118.44%-93.49K | -165.16%-269.83K | 54.21%-51.91K | 18.49%264.12K | -113.93%-35.87K |
| Cash from discontinued investing activities | -3.51%-229.19K | 264.37%639.71K | -221.41K | -389.2K | ||||||
| Operating cash flow | -2.59%-984.19K | 31.59%-2.08M | -58.10%-789.89K | 27.88%-715.27K | -16.39%-959.36K | -32.95%-3.04M | -444.23%-499.63K | -15.56%-991.76K | 19.68%-733.01K | -93.24%-824.29K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 28.37%-7.18K | 50.87%-49.74K | 1,129.89%54.2K | 53.60%-32.79K | 37.05%-10.02K | 72.90%-101.23K | 95.87%-5.26K | -40.05%-70.68K | 94.49%-9.38K | 37.48%-15.91K |
| Net PPE purchase and sale | ---5.07K | -0.02%-9.22K | --55.02K | -351.51%-8.84K | --0 | 95.06%-9.21K | --0 | 62.15%-1.96K | 97.17%-4.22K | 86.37%-3.03K |
| Net intangibles purchas and sale | 78.94%-2.11K | 43.74%-40.52K | 84.53%-814 | 50.83%-23.96K | 22.22%-10.02K | 56.84%-72.02K | 94.60%-5.26K | -7.56%-48.72K | 75.40%-5.15K | -303.19%-12.88K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | 0.00%-20K | --0 | ---20K | ---- | ---- |
| Cash from discontinued investing activities | -26.78%-3.14K | -951.21%-66.41K | -2.48K | -6.32K | ||||||
| Investing cash flow | 17.43%-10.32K | -7.99%-116.14K | -5.37%-12.2K | 53.60%-32.79K | 21.47%-12.5K | 71.21%-107.55K | 90.91%-11.58K | -40.05%-70.68K | 94.49%-9.38K | 37.48%-15.91K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -2.05%839.62K | -3.58%2.51M | 535.53%597.84K | 670.63%1.23M | 42.14%857.18K | -7.21%2.61M | -272.20%-137.27K | -112.30%-214.69K | 160.49%2.36M | 684.47%603.04K |
| Net issuance payments of debt | -119.61%-193.05K | -32.09%1.53M | -926.96%-257.79K | 3,237.17%952.88K | 248.43%984.52K | 78.50%2.25M | -118.68%-25.1K | -102.44%-30.37K | 6,030.11%1.79M | 416.23%282.56K |
| Net common stock issuance | ---- | -57.29%415.84K | --574 | --415.27K | ---- | --973.7K | --0 | --0 | --973.7K | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest paid (cash flow from financing activities) | -39.77%-177.99K | 58.25%-257.99K | 125.28%28.35K | 22.39%-143.05K | -552.51%-127.34K | -1,030.41%-617.93K | -105.19%-112.16K | ---184.32K | ---62.07K | ---19.52K |
| Net other financing activities | --1.21M | --826.7K | ---- | ---- | ---- | ---- | ---- | ---- | ---340K | 2,568.24%340K |
| Cash from discontinued financing activities | -21,328.57%-30K | -5.53%469.8K | -140 | 497.33K | ||||||
| Financing cash flow | -5.53%809.62K | -3.89%2.98M | 196.52%1.07M | 670.63%1.23M | 42.12%857.04K | 10.50%3.1M | 351.70%360.06K | -112.30%-214.69K | 160.49%2.36M | 684.47%603.04K |
| Net cash flow | ||||||||||
| Beginning cash position | -32.19%749.25K | -4.18%1.1M | 29.23%1.62M | -54.75%1.15M | -4.18%1.1M | 14.40%1.15M | -2.83%1.26M | 455.74%2.53M | 44.75%915.94K | 14.40%1.15M |
| Current changes in cash | -61.02%-184.88K | 1,726.57%783.83K | 275.69%265.55K | 137.35%477.04K | 51.58%-114.82K | -133.20%-48.19K | -8.32%-151.14K | -252.62%-1.28M | 1,013.93%1.62M | 36.78%-237.15K |
| Cash adjustments other than cash changes | 145.23%262.33K | ---1.14M | ---- | ---- | ---580.05K | --0 | ---- | ---- | ---- | ---- |
| End cash Position | 101.62%826.7K | -32.19%749.25K | -32.19%749.25K | 29.23%1.62M | -55.23%410.03K | -4.18%1.1M | -4.18%1.1M | -2.83%1.26M | 455.73%2.53M | 44.75%915.94K |
| Free cash from | -2.27%-991.36K | 31.77%-2.13M | -45.71%-735.69K | 28.24%-748.06K | -15.38%-969.38K | -18.24%-3.12M | -153.40%-504.89K | -14.72%-1.04M | 31.44%-742.38K | -85.88%-840.2K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg